C3 and Huntington disease: In addition, C3 mRNA increment in R6/2 brains mirrored results of transcriptional investigations displaying an increased complement biosynthesis in different brain areas of HD patients compared to healthy individuals [28,55] but again differed from Larkin et al. [49] that did not observe significant C3 expression modulation in R6/2 brain.